Drug
Paclitaxel Liposome clinical trials
A product of Paclitaxel; its studies count on that page too.
How studies write it
Studies that test it under each name
Studies by the year they started
18 studies that test it; most in 2008 (3)
| Year | Studies |
|---|---|
| 2000 | 1 |
| 2004 | 1 |
| 2008 | 3 |
| 2009 | 2 |
| 2010 | 1 |
| 2013 | 2 |
| 2014 | 3 |
| 2016 | 2 |
| 2018 | 1 |
| 2020 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 10 · Other 8
Nanjing Luye Sike Pharmaceutical Co., Ltd. (4) · Nanjing Sike Pharmaceutical Co., Ltd. (3) · Sun Yat-sen University (2) · INSYS Therapeutics Inc (2) · Qilu Hospital of Shandong University (1) · Memorial Sloan Kettering Cancer Center (1) · Shandong Luye Pharmaceutical Co., Ltd. (1) · Chinese Academy of Medical Sciences (1)
Often tested with
Tested in the same studies.
Nedaplatin (2) · Cisplatin (2) · Capecitabine (2) · Serplulimab (1) · Lenvatinib (1) · Albumin-Bound Paclitaxel (1) · Irinotecan (1) · Fluorouracil (1)
Related medicines
As reviewed, each with the page that says it.
- A dosage form of Paclitaxel
Studies
Open first, then newest update. How each study uses Paclitaxel Liposome is read from its arms, and is right about nine times in ten.
Testing it · 18
- Second-line Treatment With Serplulimab, Lenvatinib, and Paclitaxel in Advanced Gastric Cancer After Prior ImmunotherapyActive, not recruitingPhase 2Qilu Hospital of Shandong UniversityNCT05585580Written as Paclitaxel/Paclitaxel-albumin/Paclitaxel liposome
- Paclitaxel Liposome for Squamous Non-Small-cell Lung Cancer Study(LIPUSU)Status unknownPhase 4Nanjing Luye Sike Pharmaceutical Co., Ltd.NCT02996214Written as Paclitaxel Liposome
- SHR-1210 in Combination With Apatinib and Chemotherapy in Patients With Advanced Esophageal Squamous Cell CancerStatus unknownPhase 2Chinese Academy of Medical SciencesNCT03603756Written as Paclitaxel liposome
- Efficacy and Safety of Paclitaxel Liposome and S-1 as First-line Therapy in \ Advanced Pancreatic Cancer PatientsStatus unknownPhase 4Fudan UniversityNCT04217096Written as Paclitaxel liposome
- Induction Chemotherapy in Young Patients With Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownPhase 2Sun Yat-sen UniversityNCT03020329Written as Paclitaxel liposome
- Liposomal Paclitaxel Combined Nedaplatin in Treatment of Advanced or Recurrent Esophageal CarcinomaCompletedPhase 2Sun Yat-sen UniversityNCT02861690Written as Liposomal Paclitaxel
- Paclitaxel Liposome and Cisplatin as First-line Chemotherapy in Patients With Metastatic Esophageal CancerWithdrawnPhase 3Shantou University Medical CollegeNCT01998347Written as Paclitaxel liposome
- Dose Escalation and Pharmacokinetic Study of Paclitaxel Liposome Injection in Treating Patients With Advanced Solid Tumor After Failure From Conventional TreatmentsStatus unknownPhase 4Nanjing Luye Sike Pharmaceutical Co., Ltd.NCT01994031Written as Paclitaxel liposome injection
- Weekly Paclitaxel Liposome Injection Plus Cisplatin in Preoperative Treatment of Breast CancerStatus unknownNot applicableNanjing Luye Sike Pharmaceutical Co., Ltd.NCT02142010Written as paclitaxel liposome injection plus cisplatin
- Weekly and Every 3 Week Administration of Paclitaxel Liposome Injection in Metastatic Breast CancerStatus unknownPhase 4Nanjing Luye Sike Pharmaceutical Co., Ltd.NCT02142790Written as paclitaxel liposome injection
- Study on Neoadjuvant Chemotherapy for Advanced Gastric CancerStatus unknownPhase 2Peking UniversityNCT02163291Written as paclitaxel liposome
- PNU-93914 in Treating Patients With Locally Advanced or Metastatic Cancer of the EsophagusCompletedPhase 2Memorial Sloan Kettering Cancer CenterNCT00016900Written as liposomal paclitaxel
- Efficacy and Safety Study of LEP-ETU to Treat Metastatic Breast CancerCompletedPhase 2INSYS Therapeutics IncNCT01190982Written as LEP-ETU
- Comparison of Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) and Taxol® Pharmacokinetics in Patients With Advanced CancerCompletedPhase 1INSYS Therapeutics IncNCT00100139Written as Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU)
- Clinical Study of Liposomal Paclitaxel in Chinese PatientsStatus unknownPhase 1Nanjing Sike Pharmaceutical Co., Ltd.NCT00881101Written as Liposomal paclitaxel
- Dose Escalation Study of Liposomal Paclitaxel With/Without Capecitabine in Patients With Advanced Gastric CarcinomaStatus unknownPhase 1Nanjing Sike Pharmaceutical Co., Ltd.NCT00639522Written as Liposomal paclitaxel and capecitabine
- Dose Escalation Study of Liposomal Paclitaxel Plus Capecitabine in Chinese Patients With Advanced Gastric CarcinomaStatus unknownPhase 1Nanjing Sike Pharmaceutical Co., Ltd.NCT00881816Written as Liposomal paclitaxel plus capecitabine
- Pharmacokinetics Study of Liposomal Paclitaxel in HumansCompletedPhase 4Shandong Luye Pharmaceutical Co., Ltd.NCT00606515Written as Liposomal paclitaxel
Given in every arm · 6 — Paclitaxel Liposome is usual care beside what is tested
- Chemotherapy Combined With Propranolol Hydrochloride as Neoadjuvant Therapy for Advanced High-grade Serous Ovarian CancerRecruitingPhase 2Bai-Rong XiaNCT07125391Written as Paclitaxel liposome
- Induction Therapy With PD-1 Antibody Combined With Platinum-based Doublet Chemotherapy for Locally-advanced Non-small Cell Lung CancerRecruitingPhase 2Shanghai Pulmonary Hospital, Shanghai, ChinaNCT05766800Written as Liposomal paclitaxel
- Evaluating the Efficacy and Safety of Pembrolizumab Plus Standard Chemotherapy in the Neoadjuvant Treatment of Local Advanced (LA) HNSCCRecruitingPhase 3Beijing Tongren HospitalNCT06102395Written as Liposomal paclitaxel
- Sintilimab in Combination With Chemotherapy in Neoadjuvant Treatment of Potentially Resectable Esophageal CancerStatus unknownPhase 2The First Affiliated Hospital with Nanjing Medical UniversityNCT03946969Written as Liposomal Paclitaxel + Cisplatin + S-1
- Reduced-dose Radiotherapy for Low-risk Stage III Patients With Nasopharyngeal CarcinomaStatus unknownPhase 2Sun Yat-sen UniversityNCT03668730Written as Paclitaxel liposome
- Combination of Toripalimab and Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell CarcinomaStatus unknownPhase 2Wei RenNCT04644250Written as Paclitaxel liposome/Carboplatin